[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

JP2007505908A5 - - Google Patents

Download PDF

Info

Publication number
JP2007505908A5
JP2007505908A5 JP2006526993A JP2006526993A JP2007505908A5 JP 2007505908 A5 JP2007505908 A5 JP 2007505908A5 JP 2006526993 A JP2006526993 A JP 2006526993A JP 2006526993 A JP2006526993 A JP 2006526993A JP 2007505908 A5 JP2007505908 A5 JP 2007505908A5
Authority
JP
Japan
Prior art keywords
serotonin
investigating
pet
labeled
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006526993A
Other languages
English (en)
Other versions
JP2007505908A (ja
JP5069907B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/030190 external-priority patent/WO2005040169A2/en
Publication of JP2007505908A publication Critical patent/JP2007505908A/ja
Publication of JP2007505908A5 publication Critical patent/JP2007505908A5/ja
Application granted granted Critical
Publication of JP5069907B2 publication Critical patent/JP5069907B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Claims (1)

  1. １８ Ｆ標識もしくは１１Ｃ標識を付けておいた請求項１記載の化合物を陽電子放出断層撮影（ＰＥＴ）分子プローブとして含んで成るセロトニン介在障害を調べるための診断キット。
JP2006526993A 2003-09-17 2004-09-15 縮合複素環式化合物 Expired - Fee Related JP5069907B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US50452803P 2003-09-17 2003-09-17
US60/504,528 2003-09-17
US55267304P 2004-03-11 2004-03-11
US60/552,673 2004-03-11
PCT/US2004/030190 WO2005040169A2 (en) 2003-09-17 2004-09-15 Fused heterocyclic compounds as serotonin receptor modulators

Publications (3)

Publication Number Publication Date
JP2007505908A JP2007505908A (ja) 2007-03-15
JP2007505908A5 true JP2007505908A5 (ja) 2007-11-15
JP5069907B2 JP5069907B2 (ja) 2012-11-07

Family

ID=34526458

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006526993A Expired - Fee Related JP5069907B2 (ja) 2003-09-17 2004-09-15 縮合複素環式化合物

Country Status (30)

Country Link
US (5) US7402680B2 (ja)
EP (1) EP1668014B1 (ja)
JP (1) JP5069907B2 (ja)
KR (1) KR101151653B1 (ja)
CN (1) CN103788089A (ja)
AR (1) AR047218A1 (ja)
AT (1) ATE420881T1 (ja)
AU (1) AU2004283196B2 (ja)
BR (1) BRPI0414541B8 (ja)
CA (1) CA2539426C (ja)
CL (1) CL2009000943A1 (ja)
CR (1) CR8302A (ja)
CY (1) CY1109416T1 (ja)
DE (1) DE602004019118D1 (ja)
DK (1) DK1668014T3 (ja)
EA (2) EA010905B1 (ja)
EC (1) ECSP066436A (ja)
ES (1) ES2319539T3 (ja)
HK (1) HK1118550A1 (ja)
IL (2) IL174283A (ja)
IS (1) IS2756B (ja)
MX (1) MXPA06003150A (ja)
NI (1) NI200600094A (ja)
NZ (1) NZ545836A (ja)
PL (1) PL1668014T3 (ja)
PT (1) PT1668014E (ja)
SG (1) SG146683A1 (ja)
SI (1) SI1668014T1 (ja)
TW (1) TWI345565B (ja)
WO (1) WO2005040169A2 (ja)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1668014B1 (en) * 2003-09-17 2009-01-14 Janssen Pharmaceutica N.V. Fused heterocyclic compounds as serotonin receptor modulators
WO2005079845A1 (ja) * 2004-02-20 2005-09-01 Astellas Pharma Inc. 片頭痛予防薬
CN1980710B (zh) * 2004-06-30 2013-06-12 阿特西斯公司 作为5-羟色胺受体调节剂的取代的氮杂环庚烯衍生物
TW200638926A (en) * 2005-02-08 2006-11-16 Astellas Pharma Inc A therapeutic agent for irritable bowel disease
GB0513886D0 (en) * 2005-07-06 2005-08-10 Glaxo Group Ltd Novel compounds
EA014495B1 (ru) * 2005-08-04 2010-12-30 Янссен Фармацевтика Н.В. Соединения пиримидина в качестве модуляторов серотониновых рецепторов
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
WO2007018168A1 (ja) * 2005-08-08 2007-02-15 Astellas Pharma Inc. アシルグアニジン誘導体またはその塩
AU2007207508B2 (en) 2006-01-19 2011-08-18 Athersys, Inc. Thiophenyl and pyrrolyl azepines as serotonin 5-HT2c receptor ligands and uses thereof
US8012957B2 (en) 2006-03-27 2011-09-06 Janssen Pharmaceutica Nv Tetrahydro-1H-1,2,6-triaza-azulene cannabinoid modulators
PL2016064T3 (pl) * 2006-05-05 2010-08-31 Janssen Pharmaceutica Nv Sposoby wytwarzania związków zawierających pirazol
US20100029617A1 (en) * 2006-08-28 2010-02-04 Actelion Pharmaceuticals Ltd. 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulene derivatives as orexin receptor antagonists
WO2009058810A1 (en) * 2007-11-02 2009-05-07 Janssen Pharmaceutica N.V. Process for the preparation of substituted 2,4,5,6,7,8-hexahydro-1,2,6-triaza-azulene derivatives
US8404863B2 (en) 2008-01-03 2013-03-26 Allergan, Inc. Tetrahydroindoles having sphingosine-1-phosphate receptor activity
WO2010053825A1 (en) 2008-10-29 2010-05-14 Janssen Pharmaceutica Nv 2-aminopyrimidine compounds as serotonin receptor modulators
WO2010057795A1 (en) 2008-11-18 2010-05-27 F. Hoffmann-La Roche Ag Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
JP5063815B2 (ja) * 2008-11-25 2012-10-31 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ 抗腫瘍および抗神経変性剤としての二環式ピラゾールおよびイソオキサゾール誘導体
US8492374B2 (en) * 2009-04-29 2013-07-23 Industrial Technology Research Institute Azaazulene compounds
GB201004311D0 (en) 2010-03-15 2010-04-28 Proximagen Ltd New enzyme inhibitor compounds
JP5937199B2 (ja) 2011-04-21 2016-06-22 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 新規殺有害生物ピラゾール化合物
EA201490451A1 (ru) 2011-09-14 2014-12-30 Проксимаген Лимитед Новые соединения - ингибиторы ферментов
WO2013156318A1 (en) 2012-04-16 2013-10-24 Basf Se Substituted pesticidal pyrazole compounds
ES2800288T3 (es) 2012-06-20 2020-12-29 Basf Se Mezclas plaguicidas que comprenden un compuesto de pirazol
PE20151139A1 (es) * 2012-08-16 2015-08-07 Janssen Pharmaceutica Nv Pirrolopirazoles como bloqueadores del canal de calcio tipo n
WO2014063942A1 (en) 2012-10-23 2014-05-01 Basf Se Substituted pesticidal pyrazole compounds
CN105101967B (zh) 2012-12-21 2019-06-28 雅培控股公司 作为血清素5-ht2c受体配体的苯并吖庚因及其应用
US9309262B2 (en) 2013-03-13 2016-04-12 Abt Holding Company Thienylindole azepines as serotonin 5-HT2C receptor ligands and uses thereof
US9453002B2 (en) 2013-08-16 2016-09-27 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers
WO2015055497A1 (en) 2013-10-16 2015-04-23 Basf Se Substituted pesticidal pyrazole compounds
AU2015349687B2 (en) * 2014-11-21 2020-07-09 Akarna Therapeutics, Ltd. Fused bicyclic compounds for the treatment of disease
WO2016130818A1 (en) * 2015-02-11 2016-08-18 Merck Sharp & Dohme Corp. SUBSTITUTED PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
CN105503647A (zh) * 2015-12-10 2016-04-20 苏州昊帆生物科技有限公司 环丙基肼盐酸盐的制备方法
US9951039B2 (en) * 2016-04-08 2018-04-24 The Hong Kong Polytechnic University Pyrimidines for treatment of bacterial infections
KR101917264B1 (ko) * 2016-12-22 2018-11-13 한국과학기술연구원 5-ht7 수용체 조절제로 작용하는 아제핀 유도체
KR102037494B1 (ko) 2017-12-11 2019-10-28 씨제이헬스케어 주식회사 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법
WO2019137995A1 (en) 2018-01-11 2019-07-18 Basf Se Novel pyridazine compounds for controlling invertebrate pests
CN112300169B (zh) * 2019-07-26 2022-03-04 上海美迪西生物医药股份有限公司 吡咯并吡唑类衍生物、其制备方法及其在医药上的应用
KR20190120112A (ko) 2019-10-08 2019-10-23 씨제이헬스케어 주식회사 광학활성을 갖는 피페리딘 유도체의 중간체 및 이의 제조방법
MX2022008665A (es) * 2020-01-13 2022-08-10 Aptabio Therapeutics Inc Nuevo derivado de pirazol.
CN115698003B (zh) 2020-02-07 2024-10-11 加舒布鲁姆生物公司 杂环glp-1激动剂

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1197466B (de) 1962-03-22 1965-07-29 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen 5, 6, 7, 8-Tetrahydropyrido-[4, 3-d]pyrimidinen
US3312716A (en) 1964-08-11 1967-04-04 Aldrich Chem Co Inc 4-hydroxy-3-pyrrolidinemethanols
GB1422263A (en) 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US4314081A (en) 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
GB1484140A (en) 1974-04-24 1977-08-24 Wyeth John & Brother Ltd Pyrrolopyridine derivatives
US3969355A (en) 1974-11-01 1976-07-13 Morton-Norwich Products, Inc. 5-Aminoethyl-2,4-diphenylpyrimidine dihydrobromide
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
DK27383A (da) * 1982-02-17 1983-08-18 Lepetit Spa Fremgangsmaade til fremstilling af pyrazol(4,3-c)pyridiner
US4673405A (en) 1983-03-04 1987-06-16 Alza Corporation Osmotic system with instant drug availability
US4576604A (en) 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4857330A (en) 1986-04-17 1989-08-15 Alza Corporation Chlorpheniramine therapy
JPH03148265A (ja) 1989-11-01 1991-06-25 Sumitomo Chem Co Ltd ５，７―ジフェニル―４，６―ジアザインダン誘導体、その製造法およびそれを有効成分とする除草剤
US5137890A (en) * 1990-02-14 1992-08-11 Ortho Pharmaceutical Corporation 4-phenyl tetrahydropyrido(4,3-d)pyrimidines
US5053508A (en) 1990-03-09 1991-10-01 American Home Products Corporation Fused heterotricyclic imides with psychotropic activity and intermedrates thereof
US5648352A (en) 1991-09-13 1997-07-15 Merck & Co., Inc. Piperazinylcamphorsulfonyl oxytocin antagonists
DK0638071T3 (da) 1992-12-28 1997-10-27 Eisai Co Ltd Heterocykliske carboxylsyrederivater, der bindes til retenoidreceptorer (RAR)
US6677310B1 (en) 1999-04-21 2004-01-13 Nabi Ring-expanded nucleosides and nucleotides
US5843912A (en) 1994-07-06 1998-12-01 Universy Of Maryland Ring-expanded nucleosides and nucleotides
US5405848A (en) 1993-12-22 1995-04-11 Ortho Pharmaceutical Corporation Substituted thiazolylaminotetrahydropyridopyrimidines derivatives useful as platelet aggregation inhibitors
US5663178A (en) * 1995-02-06 1997-09-02 Eli Lilly And Company Tetrahydro-beta carbolines
AU1884595A (en) 1994-04-29 1995-11-29 Pfizer Inc. Novel acyclic and cyclic amides as neurotransmitter release enhancers
CA2218143A1 (en) 1995-04-18 1996-10-24 Eli Lilly And Company Method for using ergoline compounds to effect physiological and pathological functions at the 5-ht7 receptor
JP2000504677A (ja) 1996-02-09 2000-04-18 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５ｈｔ７レセプター・アンタゴニスト用のスルホンアミド誘導体
TW470745B (en) * 1996-05-23 2002-01-01 Janssen Pharmaceutica Nv Hexahydro-pyrido[4,3-b]indole derivatives
WO1997047601A1 (fr) 1996-06-11 1997-12-18 Yoshitomi Pharmaceutical Industries, Ltd. Composes heterocycliques fusionnes et leurs utilisations medicinales
GB9612884D0 (en) 1996-06-20 1996-08-21 Smithkline Beecham Plc Novel compounds
EP0912550A1 (en) 1996-06-25 1999-05-06 Smithkline Beecham Plc Sulfonamide derivatives as 5ht7 receptor antagonists
ATE296801T1 (de) 1996-06-28 2005-06-15 Meiji Seika Kaisha Tetrahydrobezindol derivate
GB9700899D0 (en) 1997-01-17 1997-03-05 Smithkline Beecham Plc Novel treatment
WO1998040385A1 (en) 1997-03-07 1998-09-17 Novo Nordisk A/S 4,5,6,7-TETRAHYDRO-THIENO[3,2-c]PYRIDINE DERIVATIVES, THEIR PREPARATION AND USE
US6177443B1 (en) 1997-03-07 2001-01-23 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
EP0905136A1 (en) * 1997-09-08 1999-03-31 Janssen Pharmaceutica N.V. Tetrahydro gamma-carbolines
US5951518A (en) 1997-10-31 1999-09-14 Teleflex, Incorporated Introducing device with flared sheath end
AU1558899A (en) 1997-11-10 1999-05-31 F. Hoffmann-La Roche Ag Isoquinoline derivatives for use against cns disorders
WO1999054303A1 (fr) 1998-04-22 1999-10-28 Meiji Seika Kaisha, Ltd. Derives tetrahydrobenzindoles actifs au plan optique
ID26861A (id) 1998-05-22 2001-02-15 Lilly Co Eli Terapi gabungan untuk pengobatan depresi refaktori
US5997905A (en) 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
WO2000024399A1 (en) 1998-10-23 2000-05-04 Sepracor Inc. Compositions and methods employing r(-) fluoxetine and other active ingredients
US6245785B1 (en) 1998-11-30 2001-06-12 Warner Lambert Company Dissolution of triprolidine hydrochloride
GB9828004D0 (en) 1998-12-18 1999-02-10 Smithkline Beecham Plc Use
GB9906624D0 (en) 1999-03-23 1999-05-19 Smithkline Beecham Plc Novel compounds
UA71951C2 (en) 1999-04-01 2005-01-17 Pfizer Prod Inc Pyrimidines as sorbitol dehydrogenase inhibitors, a pharmaceutical composition containing them, intermediate compounds and a method for the preparation of intermediate compound
GB9912701D0 (en) 1999-06-01 1999-08-04 Smithkline Beecham Plc Novel compounds
KR100691217B1 (ko) 1999-09-09 2007-03-12 구미아이 가가쿠 고교 가부시키가이샤 피리미딘 유도체 및 그것을 함유하는 제초제
WO2001029029A1 (en) 1999-10-18 2001-04-26 Smithkline Beecham P.L.C. Tetrahydrobenzindolone derivatives, their preparation and their use as 5-ht7 receptor antagonists
UA77650C2 (en) 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
CN1168728C (zh) 2000-02-04 2004-09-29 惠氏公司 吡咯并异喹啉和四氢吡咯并异喹衍生物及其作为5-ht7受体介体的应用
WO2001068585A1 (fr) 2000-03-14 2001-09-20 Fujisawa Pharmaceutical Co., Ltd. Nouveaux composes amides
US6586469B2 (en) 2000-07-25 2003-07-01 Medpointe Healthcare Inc. Antihistaminic/antitussive compositions
US7309703B2 (en) 2000-08-14 2007-12-18 Ortho Mcneil Pharmaceutical, Inc. Substituted pyrazoles
DE60136546D1 (de) * 2000-09-06 2008-12-24 Ortho Mcneil Pharm Inc Methode zum bekämpfen der allergien durch verwendung von substituierten pyrazolen
US20040267010A1 (en) 2001-02-02 2004-12-30 Forbes Ian Thomson Sulfonamide compounds, their preparation and use
EA006747B1 (ru) * 2001-02-21 2006-04-28 Янссен Фармацевтика Н.В. Производные изоксазолина в качестве антидепрессантов
US20020183519A1 (en) 2001-03-13 2002-12-05 Herbert Nar Antithrombotic carboxylic acid amides
DE10111842A1 (de) 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Antithrombotische Carbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel
US6559174B2 (en) 2001-03-20 2003-05-06 Merck & Co., Inc. N-arylsulfonyl aryl aza-bicyclic derivatives as potent cell adhesion inhibitors
US6806380B2 (en) 2001-10-02 2004-10-19 Lexicon Pharmaceuticals, Inc. Modified safe and efficient process for the environmentally friendly synthesis of imidoesters
BR0213562A (pt) * 2001-10-26 2004-08-31 Aventis Pharma Inc Benzimidazóis e análogos e seu uso como inibidores de cinases de proteìna
US6806279B2 (en) 2001-12-17 2004-10-19 Sunesis Pharmaceuticals, Inc. Small-molecule inhibitors of interleukin-2
SE0104340D0 (sv) 2001-12-20 2001-12-20 Astrazeneca Ab New compounds
US20030199542A1 (en) 2002-04-18 2003-10-23 Woods Keith W. Farnesyltransferase inhibitors
US20030199544A1 (en) 2002-04-18 2003-10-23 Woods Keith W. Farnesyltransferase inhibitors
HRP20020452A2 (en) 2002-05-23 2004-02-29 Pliva D D 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
JP2005528443A (ja) * 2002-05-30 2005-09-22 バーテックス　ファーマシューティカルズ　インコーポレイテッド Ｊａｋキナーゼおよびｃｄｋ２プロテインキナーゼのインヒビター
US20050288355A1 (en) 2002-06-20 2005-12-29 Arne Mork Combination therapy wherein a serotonin reuptake inhibitor is used
US20060135508A1 (en) 2002-07-25 2006-06-22 Manuela Villa Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
BR0312924A (pt) 2002-07-25 2005-07-12 Pharmacia Italia Spa Biciclo-pirazóis ativos como inibidores de quinase, processo para sua preparação e composições farmacêuticas compreendendo os mesmos
WO2004011467A1 (ja) 2002-07-29 2004-02-05 Hokko Chemical Industry Co., Ltd. トリアゾロピリミジン誘導体および農園芸用殺菌剤
US20040132826A1 (en) 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
US8012602B2 (en) 2002-10-30 2011-09-06 Basf Se Electroluminescent device
BRPI0406704A (pt) 2003-01-31 2005-12-20 Pfizer Prod Inc Antagonistas de 5ht~7~ e agonistas inversos
GB0308208D0 (en) 2003-04-09 2003-05-14 Glaxo Group Ltd Chemical compounds
US7145012B2 (en) * 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
GB0316128D0 (en) 2003-07-10 2003-08-13 Univ Aston Novel sulfonamide compounds
AU2004259009A1 (en) 2003-07-23 2005-02-03 Exelixis, Inc. Azepine derivatives as pharmaceutical agents
EP1668014B1 (en) 2003-09-17 2009-01-14 Janssen Pharmaceutica N.V. Fused heterocyclic compounds as serotonin receptor modulators
ATE546452T1 (de) * 2003-09-23 2012-03-15 Vertex Pharma Pyrazolopyrrolderivate als proteinkinaseinhibitoren
MXPA06003320A (es) 2003-09-24 2006-06-08 Combinatorx Inc Regimenes terapeuticos para administrar combinaciones de farmacos.
AU2004296531A1 (en) 2003-12-15 2005-06-23 H. Lundbeck A/S The combination of a serotonin reuptake inhibitor and a histamine 3 receptor antagonist, inverse agonist or partial agonist
US20050232986A1 (en) 2003-12-17 2005-10-20 David Brown Dosage form containing promethazine and another drug
US20090227562A1 (en) 2004-08-10 2009-09-10 Pfizer Inc. Combination of a Selective Noradrenaline Reuptake Unhibitor and a PDEV Inhibitor
US20060037652A1 (en) 2004-08-23 2006-02-23 Ranco Incorporated Of Delaware Reversing valve assembly with improved pilot valve mounting structure
CN101128432A (zh) 2004-12-17 2008-02-20 詹森药业有限公司 用于治疗中枢神经系统疾病的四氢异喹啉化合物
WO2006138604A1 (en) 2005-06-17 2006-12-28 Janssen Pharmaceutica N.V. Hexahydro-pyrrolo-isoquinoline compounds for the treatment of cns disorders
JP2008543880A (ja) 2005-06-17 2008-12-04 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ナフチリジン化合物
EA014495B1 (ru) 2005-08-04 2010-12-30 Янссен Фармацевтика Н.В. Соединения пиримидина в качестве модуляторов серотониновых рецепторов
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
CA2646023A1 (en) * 2006-03-10 2007-09-20 Neurogen Corporation Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
PL2016064T3 (pl) 2006-05-05 2010-08-31 Janssen Pharmaceutica Nv Sposoby wytwarzania związków zawierających pirazol
WO2008002817A1 (en) 2006-06-29 2008-01-03 Janssen Pharmaceutica N.V. Butyl and butynyl benzyl amine compounds
US20080045508A1 (en) 2006-06-29 2008-02-21 Brett Allison Substituted aminomethyl benzamide compounds
EP2049473A2 (en) 2006-06-29 2009-04-22 Janssen Pharmaceutica N.V. Substituted benzyl amine compounds
WO2008064036A1 (en) 2006-11-16 2008-05-29 Janssen Pharmaceutica N.V. Substituted phenyl propyl amines as histamine h3 receptor and serotonin transporter modulators

Similar Documents

Publication Publication Date Title
JP2007505908A5 (ja)
JP2008506632A5 (ja)
RU2463303C3 (ru) Гетероциклические модуляторы транспортеров атф-связывающей кассеты
PT103200B (pt) Sistema de tomografia por emissão de positrões (pet)
JP2007522220A5 (ja)
JP2010524959A5 (ja)
WO2009038795A3 (en) Positron emission tomography probes for imaging immune activation and selected cancers
JP2009013167A5 (ja) 有機金属錯体、発光材料、発光素子、及び発光装置
JP2009536150A5 (ja)
JP2009542225A5 (ja)
DE60312136D1 (de) Radiofluorierungsverfahren
JP2007119504A5 (ja)
JP2007217514A5 (ja)
JP2007532575A5 (ja)
JP2009504909A5 (ja)
FI20050365A0 (fi) Tietokonetomografialaitteisto
NO20092813L (no) Radiomerking via fluorinering av aziridiner
WO2010005697A3 (en) 18f-labelled three-and four-carbon acids for pet imaging
JP2008519810A5 (ja)
JP2009506986A5 (ja)
JP2007508806A5 (ja)
JP2008545704A5 (ja)
JP2007070442A5 (ja)
WO2006103509A3 (en) Methods for carbon isotope labeling synthesis by transition metal-promoted carbonylation via ketene using diazo compounds and carbon-isotope monoxide
JP2005506988A5 (ja)